Editorial Comment
Editorial Comment from Dr Namekawa to Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values
First published: 01 August 2018
No abstract is available for this article.
Conflict of interest
None declared.
References
- 1Kobayashi H, Tamura K, Tai T, Nagao K, Nakajima K. Semen cryopreservation as an oncofertility treatment in 122 Japanese men with cancer: a decade-long study. Reprod. Med. Biol. 2017; 16: 320–4.
- 2Hamano I, Hatakeyama S, Nakamura R et al. Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values. Int. J. Urol. 2018; https://doi.org/10.1111/iju.13732.
- 3Brydoy M, Fossa SD, Klepp O et al. Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer. Br. J. Cancer 2012; 107: 1833–9.
- 4Namekawa T, Imamoto T, Kato M et al. Testicular function among testicular cancer survivors treated with cisplatin-based chemotherapy. Reprod. Med. Biol. 2016; 15: 175–81.
- 5Brydoy M, Fossa SD, Klepp O et al. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur. Urol. 2010; 58: 134–40.
